AN 8 WEEK OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACAMPROSATE CALCIUM (CAMPRAL) AS AUGMENTATION THERAPY IN PATIENTS WITH ANXIETY SYMPTOMS WHO ARE ONLY PARTIAL RESPONDERS TO SSRI OR SNRI ANTIDEPRESSANTS: